Drug Profile
Research programme: adult stem cell therapies - PrimeCell
Alternative Names: PrimeCellLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator PrimeCell Therapeutics LLC
- Class
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Spinal cord injuries; Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Spinal-cord-injuries in USA (Intraspinal, Implant)
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in USA
- 02 Jul 2007 Preclinical trials in Spinal cord injuries in USA (Intraspinal)